Trial Profile
Effect of Atorvastatin on Inflammatory Atherosclerotic Plaques Assessed by FDG-PET Imaging
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary)
- Indications Atherosclerosis
- Focus Therapeutic Use
- 18 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
- 18 Nov 2013 Status changed from recruiting to completed.
- 11 Mar 2013 Planned end date changed from 1 Dec 2011 to 1 Dec 2013 as reported by ClinicalTrials.gov record.